Methods and compositions for treating rheumatoid arthritis

Details for Australian Patent Application No. 2004251750 (hide)

Owner Elan Pharmaceuticals, Inc.

Inventors Messersmith, Elizabeth; Konradi, Andrei W.; Freedman, Stephen B.; Pleiss, Michael A.; Yednock, Theodore A.; Shopp, George; Lieberburg, Ivan

Agent Mallesons

Pub. Number AU-A-2004251750

PCT Pub. Number WO2005/000244

Priority 60/482,211 25.06.03 US

Filing date 25 June 2004

Wipo publication date 6 January 2005

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2005/000244 Priority application(s): WO2005/000244

9 February 2006 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 12 Dec 2005

15 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251751-Coffee with enhanced flavor provided by 3,7-dimethylocta-1,6-dien-3-ol

2004251747-Mouth rinse compositions containing N- acyl-arginine alkyl ester salts